ClinicalTrials.gg
Not yet recruitingNCT07946471Updated Nov 18, 2026

A Clinical Trial to Evaluate the Effects of Glow Shakes Premium Collagen Meal Replacement on Body Composition, Weight Management, Skin, Hair, Nail, Gut, and Overall Health Outcomes

An interventional study of Glow Shakes Premium Collagen Meal Replacement Intervention in Weight Management, Body Composition and Overweight, sponsored by The Collagen Co. - GLP-1 Users. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by The Collagen Co. - GLP-1 Users · Not applicable, Interventional, and Treatment

Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years to 55 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-18

Among 1,484 studies in Overweight with a site in United States — 276 open to participants now, 403 under way, 69 of them phase 3. Overweight · United States.

Planned enrollment
978th of 1,370
40 · median 85
Started
2026
with 191 others
No phase
916 of 1,484
139 open now
Primary completion
2027-02
later than 128 of 401 live
Registered
1,483rd of 1,484
by date

Among the 1,484 studies in Overweight with a site in United States, this one is the 978th largest by planned enrollment of the 1,370 interventional ones that give a count, is one of 192 that started in 2026, is one of 916 with no phase, reaches primary completion later than 128 of the 401 other live ones, and was the 1,483rd registered.

Overweight

3,620 studies on the registry are indexed under Overweight; 862 are open to participants now.

Browse Overweight studies →

Open to participants now

276 of the 1,484 studies in Overweight with a site in United States are open now. Recruiting first, the newest first:

271 more — sign in →

All 276 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 535 Overweight studies recruiting now, 160 (30%) set no upper age limit and 347 (65%) stop at 75 or younger; 64 take children under 18; 205 take healthy volunteers.

This study: 18 Years to 55 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,484 studies in Overweight with a site in United States, or all of them as a file.
02

Study summary

This is a single-group, open-label, decentralized clinical trial evaluating the effects of 6 weeks of daily Glow Shakes Premium Collagen Meal Replacement consumption on body composition, weight management, and self-reported health outcomes in 40 adults aged 18-55 years with a BMI between 25-35 kg/m².

All participants will consume Glow Shakes Premium Collagen Meal Replacement twice daily, replacing two typical meals, for 6 consecutive weeks. Assessments will be conducted at Baseline, Week 2, Week 4, and Week 6 and will include validated self-report questionnaires and body composition measurements via the Withings smart scale. All study activities are conducted remotely; products are shipped directly to participants' homes and all data are submitted digitally through the Citruslabs study platform.

03

Conditions studied

  • Weight Management
  • Body Composition
  • Overweight
  • Skin Health
  • Hair Health
  • Nail Health
  • Gut Health

Browse trials for

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18-55 years at the time of enrollment.
  • between 25-35 kg/m² at screening, as confirmed via participant self-report and/or Withings smart scale measurement at Baseline.
  • Self-reported goals around weight management, body composition improvement, or overall health and wellness at the time of enrollment.
  • Willing and able to use Glow Shakes Premium Collagen Meal Replacement as a daily meal replacement (replacing two typical meals) for 6 consecutive weeks and to complete all questionnaire assessments and Withings smart scale body composition measurements at Baseline, Week 2, Week 4, and Week 6.
  • Willing to maintain current diet (except for the test product), exercise routine, and lifestyle habits for the duration of the 6-week study, without introducing any new supplements or products specifically targeting weight loss, appetite, or body composition.
  • In good general health.
  • Resides in the United States.

Exclusion criteria

Exclusion Criteria:

  • Pregnant or breastfeeding at the time of enrollment, or planning to become pregnant during the 6-week study period.
  • Currently using GLP-1 receptor agonists, dual-incretin medications, prescription weight loss drugs, or any other prescription medication directly affecting appetite or body weight.
  • Known allergy or intolerance to any ingredient in the Glow Shakes formulation, including milk protein, whey protein, or collagen-derived (bovine) ingredients.
  • Diagnosed with a serious medical condition requiring medical nutritional management, including but not limited to Type 1 diabetes, active cancer, or severe renal or hepatic disease.
  • Currently testing, or plan to in the next 6 weeks, a product for another research study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Glow Shakes Premium Collagen Meal Replacement Arm

    Dietary Supplement: Glow Shakes Premium Collagen Meal Replacement Intervention

Interventions

  • Dietary supplementGlow Shakes Premium Collagen Meal Replacement Intervention

    All participants will consume Glow Shakes Premium Collagen Meal Replacement twice daily (replacing two meals) for 6 weeks. Assessments will be conducted at four timepoints: Baseline, Week 2, Week 4, and Week 6. Assessments will include validated self-report questionnaires and body composition measurements via the Withings smart scale.

06

What researchers measure

Primary outcomes

  1. Change in Body Weight

    Change in body weight (kg) from Baseline to Week 6 as measured by the Withings smart scale (participant self-administered at home)

    Time frame: Baseline to Week 6

  2. Change in Body Fat Percentage

    Change in body fat percentage (%) from Baseline to Week 6 as measured by the Withings smart scale (participant self-administered at home)

    Time frame: Baseline to Week 6

Secondary outcomes

  1. Change in Self-Reported Weight Management Score

    Change from Baseline in self-reported weight management scores as assessed via self-report questionnaire

    Time frame: Baseline, Week 2, Week 4, and Week 6

  2. Change in Self-Reported Hunger Intensity

    Change from Baseline in self-reported hunger intensity as assessed via self-report questionnaire

    Time frame: Baseline, Week 2, Week 4, and Week 6

  3. Change in Self-Reported Satiety Duration

    Change from Baseline in self-reported satiety duration as assessed via self-report questionnaire

    Time frame: Baseline, Week 2, Week 4, and Week 6

  4. Change in Self-Reported Food Craving Score

    Change from Baseline in self-reported food craving scores as assessed via the Food Cravings Questionnaire-Trait Reduced (FCQ-T-reduced)

    Time frame: Baseline, Week 2, Week 4, and Week 6

  5. Change in Self-Reported Skin Health Score

    Change from Baseline in self-reported skin health scores as assessed via self-report questionnaire

    Time frame: Baseline, Week 2, Week 4, and Week 6

  6. Change in Self-Reported Hair Health Score

    Change from Baseline in self-reported hair health scores as assessed via self-report questionnaire

    Time frame: Baseline, Week 2, Week 4, and Week 6

  7. Change in Self-Reported Nail Health Score

    Change from Baseline in self-reported nail health scores as assessed via self-report questionnaire

    Time frame: Baseline, Week 2, Week 4, and Week 6

  8. Change in Self-Reported Gut Comfort and Digestive Symptom Score

    Change from Baseline in self-reported gut comfort and digestive symptom scores as assessed via self-report questionnaire

    Time frame: Baseline, Week 2, Week 4, and Week 6

  9. Participant-Reported Product Satisfaction

    Participant-reported product satisfaction, acceptability, and tolerability as assessed via product satisfaction questionnaire

    Time frame: Week 6

  10. Participant-Reported Product Tolerability

    Participant-reported tolerability of the study product as assessed via product satisfaction questionnaire

    Time frame: Week 6

  11. Participant-Reported Overall Product Experience

    Participant-reported overall experience with the study product as assessed via product satisfaction questionnaire

    Time frame: Week 6

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Feb 2027, 3 months later.

Of 113 industry-sponsored interventional studies with no phase under Overweight, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 25. This study's planned 3 months is below that.

Counting every sponsor, half of 1,424 studies reached it within 17 months; a quarter within 7 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2026
First posted
Nov 18, 2026
StartEst.
Nov 2026
Primary completionEst.
Feb 2027
CompletionEst.
Feb 2027
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07946471
Lead sponsor
The Collagen Co. - GLP-1 Users
Collaborators
Citruslabs
Responsible party
Sponsor
First posted
Nov 18, 2026
Start date
Nov 2026 (estimated)
Primary completion
Feb 2027 (estimated)
Completion
Feb 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

Izaak Woodley
Contact
izaakwoodley@thecollagen.co

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion